Randall L. Beane

Array ( [id] => 1565723 [patent_doc_number] => 06339140 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'SSX family proteins' [patent_app_type] => B1 [patent_app_number] => 09/796780 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3665 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339140.pdf [firstpage_image] =>[orig_patent_app_number] => 09796780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521736 [patent_doc_number] => 06414130 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'HER-2 binding antagonists' [patent_app_type] => B1 [patent_app_number] => 09/630155 [patent_app_country] => US [patent_app_date] => 2000-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12366 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414130.pdf [firstpage_image] =>[orig_patent_app_number] => 09630155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535582 [patent_doc_number] => 06489444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Human lysyl hydroxylase-like protein' [patent_app_type] => B1 [patent_app_number] => 09/593826 [patent_app_country] => US [patent_app_date] => 2000-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21773 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489444.pdf [firstpage_image] =>[orig_patent_app_number] => 09593826 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494465 [patent_doc_number] => 06403327 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Diagnostic method using expression of MN/CA9 protein in ASCUS Pap smears' [patent_app_type] => B1 [patent_app_number] => 09/572756 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 21 [patent_no_of_words] => 4588 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403327.pdf [firstpage_image] =>[orig_patent_app_number] => 09572756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1496141 [patent_doc_number] => 06403783 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Nucleic acid which encodes the tumor marker ZSIG62' [patent_app_type] => B1 [patent_app_number] => 09/493565 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32745 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403783.pdf [firstpage_image] =>[orig_patent_app_number] => 09493565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6358053 [patent_doc_number] => 20020058251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'DIAGNOSTIC METHOD USING EXPRESSION OF MN/CA9 PROTEIN IN AGUS PAP SMEARS' [patent_app_type] => new [patent_app_number] => 09/461938 [patent_app_country] => US [patent_app_date] => 1999-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9552 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058251.pdf [firstpage_image] =>[orig_patent_app_number] => 09461938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4366672 [patent_doc_number] => 06287790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Utilization of nuclear structural proteins for targeted therapy and detection of proliferative and differentiation disorders' [patent_app_type] => 1 [patent_app_number] => 9/452294 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18262 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287790.pdf [firstpage_image] =>[orig_patent_app_number] => 452294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4300034 [patent_doc_number] => 06251616 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-26 [patent_title] => 'Methods and assay kits for detecting altered mononuclear cell phenotype related to a pro-tumor immune response' [patent_app_type] => 1 [patent_app_number] => 9/435289 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 19687 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/251/06251616.pdf [firstpage_image] =>[orig_patent_app_number] => 435289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4416850 [patent_doc_number] => 06224866 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors' [patent_app_type] => 1 [patent_app_number] => 9/411116 [patent_app_country] => US [patent_app_date] => 1999-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 14560 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/224/06224866.pdf [firstpage_image] =>[orig_patent_app_number] => 411116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1407502 [patent_doc_number] => 06528270 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'Methods for identifying compounds for treatment of cell proliferative disorders associated with adaptor protein interactions' [patent_app_type] => B1 [patent_app_number] => 09/393585 [patent_app_country] => US [patent_app_date] => 1999-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 22 [patent_no_of_words] => 21822 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528270.pdf [firstpage_image] =>[orig_patent_app_number] => 09393585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475629 [patent_doc_number] => 06388065 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'DNA for evaluating the progression potential of cervical lesions' [patent_app_type] => B1 [patent_app_number] => 09/308984 [patent_app_country] => US [patent_app_date] => 1999-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2938 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388065.pdf [firstpage_image] =>[orig_patent_app_number] => 09308984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4265005 [patent_doc_number] => 06306600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Rapidly degrading GFP-fusion proteins and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/364946 [patent_app_country] => US [patent_app_date] => 1999-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9018 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306600.pdf [firstpage_image] =>[orig_patent_app_number] => 364946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4306839 [patent_doc_number] => 06326466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-04 [patent_title] => 'Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner' [patent_app_type] => 1 [patent_app_number] => 9/230548 [patent_app_country] => US [patent_app_date] => 1999-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23054 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/326/06326466.pdf [firstpage_image] =>[orig_patent_app_number] => 230548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1380574 [patent_doc_number] => 06548064 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-15 [patent_title] => 'Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules' [patent_app_type] => B1 [patent_app_number] => 09/344040 [patent_app_country] => US [patent_app_date] => 1999-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9930 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/548/06548064.pdf [firstpage_image] =>[orig_patent_app_number] => 09344040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4287952 [patent_doc_number] => 06268334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Peptide antagonists of DP transcription factors' [patent_app_type] => 1 [patent_app_number] => 9/308935 [patent_app_country] => US [patent_app_date] => 1999-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11863 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268334.pdf [firstpage_image] =>[orig_patent_app_number] => 308935 [rel_patent_id] =>[rel_patent_doc_number] =>)